Safety and pharmacokinetics of famciclovir single 1500 mg dose in adolescents with recurrent herpes labialis.

Journal of Drugs in DermatologyVol. 8 Nbr. 6, June 2009

Linked as:

Summary


DERMATOMYOSITIS

See the full content of this document

Extract


Safety and pharmacokinetics of famciclovir single 1500 mg dose in adolescents with recurrent herpes labialis.

Sponsored by Novartis Pharmaceuticals. This study will assess...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company